Sildenafil for Secondary Pulmonary Hypertension Due to Valvular Disease
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the clinical efficacy of the mid-term treatment with
sildenafil in patients with persistent moderate or severe pulmonary hypertension (PH) after a
heart valve intervention.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital General Universitario Gregorio Marañon
Collaborators:
Fundación de Investigación en Red en Enfermedades Cardiovasculares Instituto de Salud Carlos III